Market Cap 1.69B
Revenue (ttm) 441.33M
Net Income (ttm) 9.77M
EPS (ttm) N/A
PE Ratio 59.35
Forward PE 59.35
Profit Margin 2.21%
Debt to Equity Ratio 0.48
Volume 306,789
Avg Vol 386,542
Day's Range N/A - N/A
Shares Out 47.88M
Stochastic %K 27%
Beta 1.59
Analysts Strong Sell
Price Target $51.43

Company Profile

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac and preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts, including E-vita Open NEO, E-vita Open Plus, ascyrus medical dissection stent hybrid prosthesis, E-vita THOR...

Industry: Medical Devices
Sector: Healthcare
Phone: 770 419 3355
Address:
1655 Roberts Boulevard NW, Kennesaw, United States
savybull90
savybull90 Feb. 25 at 8:15 PM
$AORT bottoms in
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Feb. 23 at 2:50 AM
$AORT another potential m&A target
0 · Reply
savybull90
savybull90 Feb. 13 at 7:28 PM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 12 at 9:17 PM
$AORT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.05 up 112.82% YoY • Reported revenue of $115.99M up 19.20% YoY • Artivion expects full year 2026 revenues of $486M to $504M, reflecting 10% to 14% adjusted constant currency growth, and adjusted EBITDA of $105M to $110M, an 18% to 22% increase.
0 · Reply
InflationSwapX
InflationSwapX Feb. 4 at 1:30 PM
$AORT is a medical device company focused on aortic health; its growth is tied to the adoption of endovascular repair techniques over open surgery, a steady but competitive market.
0 · Reply
CrazyRick7
CrazyRick7 Jan. 19 at 3:49 AM
$AORT Fundamental models project future revenue and earnings growth for AORT, suggesting accelerating growth over the next several years if estimates hold. Long-term EPS growth is forecast to be significant in some projections
0 · Reply
CrazyRick7
CrazyRick7 Jan. 19 at 3:48 AM
$AORT 50-75$
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 16 at 9:58 PM
$AORT RSI: 27.74, MACD: -0.6561 Vol: 1.54, MA20: 45.13, MA50: 45.38 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 30 at 6:44 AM
$AORT Current Stock Price: $46.35 Contracts to trade: $45 AORT Jan 16 2026 Call Entry: $4.05 Exit: $7.21 ROI: 78% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ComprehensionCaptain
ComprehensionCaptain Dec. 26 at 7:36 AM
$AORT Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Future returns will be dictated by execution quality, not headlines.
0 · Reply
Latest News on AORT
Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript

Feb 12, 2026, 11:04 PM EST - 13 days ago

Artivion, Inc. (AORT) Q4 2025 Earnings Call Transcript


Artivion Continues Building Toward Bigger And Better Things

Dec 29, 2025, 2:04 PM EST - 2 months ago

Artivion Continues Building Toward Bigger And Better Things


Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 11:46 PM EST - 3 months ago

Artivion, Inc. (AORT) Q3 2025 Earnings Call Transcript


Artivion Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 3 months ago

Artivion Reports Third Quarter 2025 Financial Results


Artivion to Participate in the Stifel 2025 Healthcare Conference

Oct 29, 2025, 4:10 PM EDT - 4 months ago

Artivion to Participate in the Stifel 2025 Healthcare Conference


Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 2:30 PM EDT - 7 months ago

Artivion, Inc. (AORT) Q2 2025 Earnings Call Transcript


Artivion Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 7 months ago

Artivion Reports Second Quarter 2025 Financial Results


Artivion to Participate in Upcoming Investor Conferences

Jul 30, 2025, 4:10 PM EDT - 7 months ago

Artivion to Participate in Upcoming Investor Conferences


Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript

May 5, 2025, 10:37 PM EDT - 10 months ago

Artivion, Inc. (AORT) Q1 2025 Earnings Call Transcript


Artivion Reports First Quarter 2025 Financial Results

May 5, 2025, 4:05 PM EDT - 10 months ago

Artivion Reports First Quarter 2025 Financial Results


Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript

Feb 24, 2025, 11:00 PM EST - 1 year ago

Artivion, Inc. (AORT) Q4 2024 Earnings Call Transcript


Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript

Nov 9, 2024, 12:02 PM EST - 1 year ago

Artivion, Inc. (AORT) Q3 2024 Earnings Call Transcript


Artivion Reports Third Quarter 2024 Financial Results

Nov 7, 2024, 4:05 PM EST - 1 year ago

Artivion Reports Third Quarter 2024 Financial Results


Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript

Aug 10, 2024, 2:45 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q2 2024 Earnings Call Transcript


Artivion Reports Second Quarter 2024 Financial Results

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports Second Quarter 2024 Financial Results


Artivion Amends Agreements with Endospan

Jul 1, 2024, 4:05 PM EDT - 1 year ago

Artivion Amends Agreements with Endospan


Data-Driven Growth Fuels More Upside For Overlooked Artivion

Jun 21, 2024, 5:01 PM EDT - 1 year ago

Data-Driven Growth Fuels More Upside For Overlooked Artivion


Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript

May 6, 2024, 10:47 PM EDT - 1 year ago

Artivion, Inc. (AORT) Q1 2024 Earnings Call Transcript


Artivion Reports First Quarter 2024 Financial Results

May 6, 2024, 4:05 PM EDT - 1 year ago

Artivion Reports First Quarter 2024 Financial Results


Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Feb 15, 2024, 8:22 PM EST - 2 years ago

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript


savybull90
savybull90 Feb. 25 at 8:15 PM
$AORT bottoms in
0 · Reply
TheWolfOfSanFran
TheWolfOfSanFran Feb. 23 at 2:50 AM
$AORT another potential m&A target
0 · Reply
savybull90
savybull90 Feb. 13 at 7:28 PM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 12 at 9:17 PM
$AORT Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.05 up 112.82% YoY • Reported revenue of $115.99M up 19.20% YoY • Artivion expects full year 2026 revenues of $486M to $504M, reflecting 10% to 14% adjusted constant currency growth, and adjusted EBITDA of $105M to $110M, an 18% to 22% increase.
0 · Reply
InflationSwapX
InflationSwapX Feb. 4 at 1:30 PM
$AORT is a medical device company focused on aortic health; its growth is tied to the adoption of endovascular repair techniques over open surgery, a steady but competitive market.
0 · Reply
CrazyRick7
CrazyRick7 Jan. 19 at 3:49 AM
$AORT Fundamental models project future revenue and earnings growth for AORT, suggesting accelerating growth over the next several years if estimates hold. Long-term EPS growth is forecast to be significant in some projections
0 · Reply
CrazyRick7
CrazyRick7 Jan. 19 at 3:48 AM
$AORT 50-75$
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 16 at 9:58 PM
$AORT RSI: 27.74, MACD: -0.6561 Vol: 1.54, MA20: 45.13, MA50: 45.38 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 30 at 6:44 AM
$AORT Current Stock Price: $46.35 Contracts to trade: $45 AORT Jan 16 2026 Call Entry: $4.05 Exit: $7.21 ROI: 78% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ComprehensionCaptain
ComprehensionCaptain Dec. 26 at 7:36 AM
$AORT Volatility reflects unresolved questions around how strategy converts into durable results. Strategic direction should avoid unnecessary detours. If milestones track on schedule, sentiment can re-rate faster than fundamentals. Future returns will be dictated by execution quality, not headlines.
0 · Reply
REDBEAR
REDBEAR Dec. 25 at 5:45 PM
$AORT masive b/o incoming.
0 · Reply
StockConsultant
StockConsultant Dec. 18 at 2:26 PM
$AORT Artivion stock, strong day, watch for a top of range breakout at https://stockconsultant.com/?AORT
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 12 at 4:57 PM
$AORT Current Stock Price: $45.15 Contracts to trade: $50 AORT Dec 19 2025 Call Entry: $0.24 Exit: $0.33 ROI: 35% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BillionerOfKing
BillionerOfKing Nov. 13 at 12:27 PM
$AORT Current Stock Price: $47.63 Contracts to trade: $50 AORT Nov 21 2025 Call Entry: $0.45 Exit: $0.82 ROI: 83% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
smartkarma
smartkarma Nov. 10 at 3:11 AM
$AORT | Primer: Artivion (AORT US) - Nov 2025 "Artivion is a niche leader in aortic repair, demonstrating strong revenue growth driven by its key product families: On-X mechanical heart..." - αSK (Smartkarma) Read more: https://www.smartkarma.com/insights/primer-artivion-aort-us-nov-2025
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 9:36 PM
Canaccord Genuity has updated their rating for Artivion ( $AORT ) to Buy with a price target of 51.
0 · Reply
StockConsultant
StockConsultant Nov. 7 at 2:28 PM
$AORT Artivion stock, nice continuation breakout at https://stockconsultant.com/?AORT
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:42 PM
Citizens has adjusted their stance on Artivion ( $AORT ), setting the rating to Market Outperform with a target price of 47 → 53.
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 10:01 AM
Needham has updated their rating for Artivion ( $AORT ) to Buy with a price target of 58.
0 · Reply
Wigglyick
Wigglyick Nov. 7 at 2:45 AM
$AORT another Algo-Doozio pick. Artivion , a med devise co that develope solutions addressing cardiac & vascular surgery challenges. Popped on August ER and based, breaking out again.
0 · Reply
Estimize
Estimize Nov. 6 at 4:00 PM
$AORT reports after the close, Estimize Consensus +0.01 EPS and +0.40M Revs compared to WS http://www.estimize.com/aort/fq3-2025?utm_conten
0 · Reply
Doozio
Doozio Oct. 18 at 3:34 PM
$AORT a say out of the tightness 🐒🍌🧠⏰♾️
0 · Reply